norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

<strong>Background & Aim</strong> Primary sclerosing cholangitis (PSC) represents a devastating bile duct disease, currently lacking effective medical therapy. 24-norursodeoxycholic acid (norUDCA) is a side chain-shortened C23 homologue of UDCA and has shown potent anti-cholestat...

Full description

Bibliographic Details
Main Authors:	Fickert, P, Hirschfield, G, Denk, G, Marschall, H, Altorjay, I, Färkkilä, M, Schramm, C, Spengler, U, Chapman, R, Bergquist, A, Schrumpf, E, Nevens, F, Trivedi, P, Reiter, F, Tornai, I, Halilbasic, E, Greinwald, R, Pröls, M, Manns, M, Trauner, M, European Psc Norudca Study Group
Format:	Journal article
Language:	English
Published:	Elsevier 2017

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Similar Items